رجوع
نطاق اليوم
KWD 12.63
KWD 13.18
نطاق 52 أسبوعًا
KWD 5.90
KWD 28.25
حجم التداول
3,336,008
متوسط 50 يوم / 200 يوم
KWD 12.99
/
KWD 12.58
الإغلاق السابق
KWD 13.11
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -3.7 | 0.4 |
| P/B | 2.3 | 2.9 |
| ROE % | -53.5 | 3.7 |
| Net Margin % | -609.9 | 3.9 |
| Rev Growth 5Y % | 19.6 | 10.0 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 19.380
+51.3%
Low: KWD 7.000
High: KWD 48.000
ربحية السهم المستقبلية
-KWD 3.619
الإيرادات المقدّرة
59 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 8.763
-KWD 1.786 – KWD 99.210
|
2.5 B | 5 |
| FY2029 |
KWD 3.862
-KWD 0.787 – KWD 43.722
|
1.6 B | 10 |
| FY2028 |
-KWD 0.688
-KWD 3.570 – KWD 15.817
|
670 M | 12 |
النقاط الرئيسية
Revenue grew 19.62% annually over 5 years — strong growth
Debt/Equity of 0.14 — conservative balance sheet
Negative free cash flow of -354.66M
PEG of 0.09 suggests growth is underpriced
Capital efficient — spends only 8.54% of revenue on capex
النمو
Revenue Growth (5Y)
19.62%
Revenue (1Y)16.92%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-53.48%
ROIC-43.25%
Net Margin-609.85%
Op. Margin-651.67%
الأمان
Debt / Equity
0.14
Current Ratio5.08
Interest Coverage0.00
التقييم
P/E Ratio
-3.67
P/B Ratio2.25
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16.92% | Revenue Growth (3Y) | 36.58% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 19.62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 67.67M | Net Income (TTM) | -412.69M |
| ROE | -53.48% | ROA | -49.01% |
| Gross Margin | 76.47% | Operating Margin | -651.67% |
| Net Margin | -609.85% | Free Cash Flow (TTM) | -354.66M |
| ROIC | -43.25% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.14 | Current Ratio | 5.08 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -3.67 | P/B Ratio | 2.25 |
| P/S Ratio | 22.36 | PEG Ratio | 0.09 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.51B | Enterprise Value | 1.45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 67.67M | 57.88M | 36.28M | 52.12M | 33.05M |
| Net Income | -412.69M | -519.02M | -481.19M | -474.19M | -267.89M |
| EPS (Diluted) | -3.81 | -5.25 | -5.42 | -6.16 | -3.78 |
| Gross Profit | 51.75M | 47.59M | 27.30M | 44.55M | 26.16M |
| Operating Income | -440.99M | -534.26M | -515.29M | -458.16M | -267.85M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 842.13M | 1.19B | 1.30B | 1.52B | 1.29B |
| Total Liabilities | 170.73M | 319.06M | 250.81M | 284.53M | 254.22M |
| Shareholders' Equity | 671.39M | 871.96M | 1.05B | 1.24B | 1.04B |
| Total Debt | 93.33M | 210.20M | 115.35M | 130.70M | 74.02M |
| Cash & Equivalents | 155.46M | 189.18M | 226.75M | 523.51M | 123.41M |
| Current Assets | 527.71M | 639.86M | 998.33M | 1.22B | 769.30M |
| Current Liabilities | 103.88M | 110.85M | 115.21M | 126.55M | 125.83M |